BMC Medical Education BioMed Central (2010)
Regina Kulier, Julie Hadley, Susanne Weinbrenner, Berrit Meyerrose, Tamas Decsi, Andrea R Horvath, ...
Research article Harmonising Evidence-based medicine teaching: a study of the
BMC Medical Education BioMed Central Correspondence (2007)
Jose I Emparanza, Julie Hadley, Regina Kulier, Susanne Weinbrenner, Theodoros N Arvanitis, A Burls, ...
A clinically integrated curriculum in Evidence-based Medicine for just-in-time learning through on-the-job training: The EU-EBM
Chen, Y-F, Jobanputra, P, Barton, P, Jowett, S, Bryan, S, Clark, W, ...
Objectives: This report reviews the clinical effectiveness and cost-effectiveness of adalimumab, etanercept and infliximab, agents that inhibit tumour necrosis factor-a (TNF-a), when used in the...
Connock, M., Burls, A., Frew, E., Fry-Smith, A., Juarez-Garcia, A., McCabe, C., ...
see also www.hta.ac.uk
Chen, Y-F, Jobanputra, P, Barton, P, Jowett, S, Bryan, S, Clark, W, ...
Objectives: This report reviews the clinical effectiveness and cost-effectiveness of adalimumab, etanercept and infliximab, agents that inhibit tumour necrosis factor-a (TNF-a), when used in the...
Chen, Y-F, Jobanputra, P, Barton, P, Jowett, S, Bryan, S, Clark, W, ...
Objectives: This report reviews the clinical effectiveness and cost-effectiveness of adalimumab, etanercept and infliximab, agents that inhibit tumour necrosis factor-a (TNF-a), when used in the...
BMC Medical Education BioMed Central Debate Sicily statement on evidence-based practice (2005)
Martin Dawes, William Summerskill, Paul Glasziou, Antonino Cartabellotta, Janet Martin, Kevork Hopayian, ...
© 2005 Dawes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis (2004)
Jobanputra, P., Wilson, J., Douglas, K., Burls, A.
Objective. To determine the current disease-modifying anti-rheumatic drug (DMARD) preferences of UK consultant rheumatologists. Methods. A questionnaire was sent in May 2002. We asked which DMARD(s)...
A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis (2003)
Jobanputra, P., Wilson, J., Douglas, K., Burls, A.
Objective. To determine the current disease-modifying anti-rheumatic drug (DMARD) preferences of UK consultant rheumatologists. Methods. A questionnaire was sent in May 2002. We asked which DMARD(s)...
A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis (2003)
Jobanputra, P., Wilson, J., Douglas, K., Burls, A.
Objective. To determine the current disease-modifying anti-rheumatic drug (DMARD) preferences of UK consultant rheumatologists. Methods. A questionnaire was sent in May 2002. We asked which DMARD(s)...
Jobanputra, P, Parry, D, Fry-Smith, A, Burls, A
Background Proposed service Autologous chondrocyte transplantation (ACT) is a novel surgical approach used to treat full-thickness cartilage defects in knee joints. Small grafts of normal cartilage...
Jobanputra, P, Parry, D, Fry-Smith, A, Burls, A
Background Proposed service Autologous chondrocyte transplantation (ACT) is a novel surgical approach used to treat full-thickness cartilage defects in knee joints. Small grafts of normal cartilage...
Jobanputra, P, Parry, D, Fry-Smith, A, Burls, A
Background Proposed service Autologous chondrocyte transplantation (ACT) is a novel surgical approach used to treat full-thickness cartilage defects in knee joints. Small grafts of normal cartilage...
BACKGROUND: Sildenafil (Viagra), a new oral drug for the treatment of erectile dysfunction, was licensed for use across Europe in 1998. AIM: To examine the effectiveness and safety of sildenafil as...
BACKGROUND: Sildenafil (Viagra), a new oral drug for the treatment of erectile dysfunction, was licensed for use across Europe in 1998. AIM: To examine the effectiveness and safety of sildenafil as...
Skin to calcaneus distance in the neonate
Arena, J, Emparanza, J, Nogues, A, Burls, A
Background: Current recommendations for obtaining blood from neonates advise avoidance of the midline area of the heel and are based on postmortem studies.